$CB

BOROUGHS TIMOTHY ALAN sold (to issuer) 930 shares of CB

BOROUGHS TIMOTHY ALAN (Executive Vice President*) sold (to issuer) 930 shares of Chubb Ltd (CB) on 2026-05-21.

Original reporting
SEC EDGAR · BOROUGHS TIMOTHY ALAN
Published May 26, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CB
Neutral
high confidence
Mentioned
$CB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBNeutralLow
01

Why it matters

Because the article contains only the insider transaction details and no accompanying corporate event, it is unlikely to change Chubb’s earnings power or risk profile.

02

Market read

Traders may note the insider sale, but the disclosure lacks disclosed economics and does not indicate a new catalyst, so expected impact is limited.

03

What to watch

Absence of a 10b5-1 plan may raise scrutiny, but without additional context (e.g., repeated sales, option exercises, or large ownership changes) it remains low-signal.

Relevance 6/10Timing: Filed 2026-05-26 for a transaction dated 2026-05-21; any trading impact would be short-lived around the filing window.

Background

The filing is an SEC Form 4 insider transaction: sale to issuer (often buyback participation) by Chubb’s Executive Vice President; price and total value are not disclosed.

Company-level read

Ticker impact

$CBNeutralHigh confidence
Context

Chubb (CB) disclosed an insider sale to the issuer of 930 shares by an Executive Vice President via SEC Form 4.

Expected impact

Minimal near-term impact; any reaction is likely noise unless follow-on filings indicate a broader pattern.

Evidence & confidence

Form 4 shows a small, disclosed-share count sale with price/value not provided and no stated corporate event (earnings, deal, litigation, or guidance).

Market effects

No clear read-across to insurers; this appears company-specific and not tied to sector-wide catalysts.

None indicated; disclosure is US SEC EDGAR with no geographic operational change.

None indicated; no international deal/regulatory action mentioned.

Counterpoint

Insider sales can reflect diversification or liquidity needs rather than bearish expectations, especially when price/value aren’t disclosed.

Key entities

  • Chubb Ltd

    Subject of the SEC Form 4 insider sale to the issuer of 930 shares by an Executive Vice President.

  • BOROUGHS TIMOTHY ALAN

    Executive Vice President who sold 930 shares to the issuer; holdings after transaction: 10,339 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBMed

Fed hikes again - an AI-Picked insurer is still cashing in

The Federal Reserve raised rates, impacting markets. Investing.com's AI models show varied portfolio performance. Chubb (CB) is benefiting from higher rates, with a 1.13% monthly gain, due to its Treasury investments. CB's earnings beat estimates, and it trades at a low forward P/E. The Fed's decision is affecting sectors differently.

$CBMed

Is Wall Street Bullish or Bearish on Chubb Limited Stock?

Chubb Limited (CB), a global insurer, has seen its stock rise 26% over the past year, outpacing the S&P 500. In 2026, it gained 10.2%, underperforming the index. CB offers a 1.20% dividend yield and has increased payouts for 18 years. Analysts expect 10.7% EPS growth this year. The consensus rating is 'Moderate Buy' with a mean price target of $369.36, suggesting 6.1% upside.

$CBMed

What Chubb (CB)'s Earnings Beat and Completed Buyback Mean For Shareholders

Chubb Limited (CB) reported Q2 2026 earnings above analyst estimates, citing higher underwriting and investment income and 3.6% net premium written growth across Property & Casualty and Life. The company also completed a US$4.45 billion multi-year buyback totaling 14,811,112 shares. Chubb Tempest Re named James Wixtead Executive Chairman and Michael O’Donnell President.

$BAXMed

This week in insurance: Catastrophe losses ease, Allianz buys HSBC Life Singapore, Chubb launches shopping cover

A weekly insurance roundup said Asia’s insured natural-catastrophe losses in H1 2026 were under $2.0b, the lowest six-month total since 2017, citing Gallagher Re. It also covered rising transaction-risk claims and new products. Deal news included Allianz buying HSBC Life Singapore for S$2.7b, and Sompo International agreeing to buy Fator Seguradora in Brazil.